✦ LIBER ✦

Establishment of a human colony-stimulating-factor-producing cell line from an undifferentiated large cell carcinoma of the lung

✍ Scribed by Tetsuro Okabe; Michio Fujisawa; Hidetoshi Kudo; Hiomi Honma; Nakaaki Ohsawa; Fumimaro Takaku

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 630 KB
Volume: 54
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840915)54:6<1024::aid-cncr2820540616>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishment of a human undifferentiate

Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines

✍ T. Enomoto; H. Sugawa; D. Inoue; M. Miyamoto; S. Kosugi; T. Takahashi; I. Yamamo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 1011 KB

Granulocyte colony-stimulating factor-pr

Granulocyte colony-stimulating factor-producing small-cell carcinoma of the uterine cervix: Report of a case

✍ Akihiko Watanabe; Toshiki Wachi; Hiroko Omi; Hiroshi Nishii; Kazuhiko Ochiai; Ta 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 2 views

Isolation of a polyamine transport defic

Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157

✍ Dan Shao; Lei Xiao; Hyo-Chol Ha; Robert A. Casero Jr. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

In an effort to study the mechanism underlying the observed phenotype-specific response of human lung cancer cell lines to a polyamine analogue, N1,N12-bis(ethyl)spermine(BESpm), we have isolated a BESpm resistant cell line from the BESpm-sensitive large cell lung carcinoma line NCI H157. The mutant

A combination of stem cell factor and gr

A combination of stem cell factor and granulocyte colony-stimulating factor enhances the growth of human progenitor B cells supported by murine stromal cell line MS-5

✍ Masamichi Nishihara; Yuka Wada; Kazuo Ogami; Yasuhiro Ebihara; Takefumi Ishii; K 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Dose escalation study of carboplatin wit

Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan

✍ Nobuyuki Katakami; Minoru Takada; Shunichi Negoro; Katsuyasu Ota; Jiro Fujita; K 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

## BACKGROUND. We performed a Phase 1-11 trial to determine the maximum tolerated dose of carboplatin (CBDCA) with a fixed dose of VP-16 and granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC) patients. ## METHODS. Treatment consisted of a starting dose of CBDCA, 400